Akoya biosciences sets a new standard for scaling spatial biology with the launch of 2.0 platforms

Marlborough, mass., sept. 19, 2023 (globe newswire) -- akoya biosciences, inc. (nasdaq: akya) (“akoya”), the spatial biology company®, today highlighted the industry-leading scale and speed in whole-slide, spatial biology workflows enabled by the recently launched phenocycler®-fusion 2.0 and phenoimager® ht 2.0 platform upgrades. enhancements to the phenocycler-fusion 2.0 system allow customers to process twice as many samples per week, making it the highest throughput spatial discovery platform on the market. the phenoimager 2.0 platform delivers a 5x workflow improvement by enabling rapid real-time image analysis directly on the ht instrument. with an unprecedented ability to perform whole-slide spatial biology at scale, akoya's customers can accelerate progress towards new discoveries, identification of clinically relevant biomarkers, and development of novel spatial signatures.
AKYA Ratings Summary
AKYA Quant Ranking